IMP3-saRNA Vaccine in Advanced NSCLC

NCT07561723 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

BIOLOGICAL: IMP3-saRNA (YMN-136) Vaccine

Sponsor

West China Hospital